Prevention of death in chronic kidney disease: the role of implantable cardioverter defibrillators.
Cardiac arrhythmia is associated with increased mortality and morbidity in patients with chronic kidney disease (CKD) (McCullough & Sandberg, 2004). The implantable cardioverter defibrillator (ICD) has been shown to decrease mortality of patients with cardiac arrhythmias, yet CKD patients are usually excluded from clinical trials. This article discusses the ICD as it relates to CKD patients, including care of the patient and possible complications that can be encountered.
Turner
Suzette
S
Division of Cardiology, Sunnybrook Health Sciences Centre, Toronto, ON. Suzette.Turner@sunnybrook.ca
Onalan
Orhan
O
Bickle
Barbara
B
D001145:Arrhythmias, Cardiac / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control*; D001334:Automobile Driving; D015897:Comorbidity; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D017147:Defibrillators, Implantable / Q000009:adverse effects; D004867:Equipment Design; D006801:Humans; D051436:Renal Insufficiency, Chronic / Q000145:classification / Q000453:epidemiology* / Q000401:mortality; D017180:Tachycardia, Ventricular / Q000453:epidemiology